Mesenchymal stem cells suppress T cells by inducing apoptosis and through PD-1/B7-H1 interactions

Zhidong Yan1, Yongxun Zhuansun1, Guirong Liu2

  • 1Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China; Department of Respiratory Medicine, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China.

Immunology Letters
|October 5, 2014
PubMed

Insights

Mesenchymal stem cells (MSCs) suppress T cells partly via the PD-1/B7-H1 pathway, increasing T cell apoptosis. This mechanism is independent of IL-10 and TGF-β1 immunosuppressive cytokines.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Mesenchymal stem cells (MSCs) are known for their immunosuppressive properties, particularly on T cells.
  • The precise molecular mechanisms underlying MSC-mediated T cell suppression remain incompletely understood.

Purpose of the Study:

  • To investigate the role of the programmed cell death-1 receptor (PD-1)/B7-H1 pathway in MSC-induced suppression of conventional CD4(+)CD25(-) T cells (Tconv).
  • To elucidate the relationship between PD-1 up-regulation, T cell apoptosis, and immunosuppressive cytokines in MSC-Tconv co-cultures.

Main Methods:

  • Co-culture assays of MSCs and Tconv with and without transwell systems.
  • Flow cytometry to assess PD-1 expression on activated Tconv.
  • Analysis of T cell apoptosis and levels of IL-10 and TGF-β1.

Main Results:

  • MSCs significantly increased PD-1 expression on activated Tconv.
  • The PD-1/B7-H1 pathway was implicated in the suppression of Tconv by MSCs.
  • Elevated PD-1 expression correlated with increased Tconv apoptosis.
  • The PD-1/B7-H1 pathway's effect was independent of IL-10 and TGF-β1.

Conclusions:

  • The PD-1/B7-H1 pathway is a key mechanism mediating MSC-induced T cell suppression and apoptosis.
  • IL-10 and TGF-β1 do not appear to mediate PD-1 up-regulation in this context.

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.5K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K